Tags: cell biologycancer, cancer immunotherapy, cell biology, cell therapy, cytokines, interleukin, tumor microenvironmentCRSimmunotherapiesPoolbeg
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Judy George MedPage Today Medical reporter, writer. | Possible Early Symptom of Creutzfeldt-Jakob Disease Identified - about 2 months ago Prion Disease Rising in the U.S. - about 1 year ago | |
| 2 | Kristen Monaco MedPage Today | ||
| 3 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 4 | Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. | STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission - 2 months ago | |
| 5 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | Poolbeg Pharma presents positive results for POLB 001 - 3 months ago Poolbeg’s cytokine release syndrome drug shows potential - about 1 year ago | |
| 6 | The Conversation Science Alert Science news. Official account. Australia | ||
| 7 | Ian Ingram MedPage Today Deputy Managing Editor.
MedPage Today. New York, New York | ||
| 8 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - about 1 year ago Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer - about 1 year ago | |
| 9 | Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA | ||
| 10 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | FDA Approves Axatilimab-csfr for cGVHD - 6 months ago |